1. Home
  2. CHRO vs FBGL Comparison

CHRO vs FBGL Comparison

Compare CHRO & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • FBGL
  • Stock Information
  • Founded
  • CHRO 2002
  • FBGL 1996
  • Country
  • CHRO United States
  • FBGL Singapore
  • Employees
  • CHRO N/A
  • FBGL N/A
  • Industry
  • CHRO
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • CHRO
  • FBGL Consumer Discretionary
  • Exchange
  • CHRO Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • CHRO 8.4M
  • FBGL 8.1M
  • IPO Year
  • CHRO 2024
  • FBGL 2025
  • Fundamental
  • Price
  • CHRO $0.95
  • FBGL $0.62
  • Analyst Decision
  • CHRO Strong Buy
  • FBGL
  • Analyst Count
  • CHRO 1
  • FBGL 0
  • Target Price
  • CHRO N/A
  • FBGL N/A
  • AVG Volume (30 Days)
  • CHRO 2.1M
  • FBGL 360.1K
  • Earning Date
  • CHRO 05-13-2025
  • FBGL 01-01-0001
  • Dividend Yield
  • CHRO N/A
  • FBGL N/A
  • EPS Growth
  • CHRO N/A
  • FBGL N/A
  • EPS
  • CHRO N/A
  • FBGL 0.04
  • Revenue
  • CHRO N/A
  • FBGL $15,607,369.00
  • Revenue This Year
  • CHRO N/A
  • FBGL N/A
  • Revenue Next Year
  • CHRO N/A
  • FBGL N/A
  • P/E Ratio
  • CHRO N/A
  • FBGL $18.50
  • Revenue Growth
  • CHRO N/A
  • FBGL 25.78
  • 52 Week Low
  • CHRO $0.45
  • FBGL $0.44
  • 52 Week High
  • CHRO $3.80
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 35.68
  • FBGL N/A
  • Support Level
  • CHRO $0.91
  • FBGL N/A
  • Resistance Level
  • CHRO $1.14
  • FBGL N/A
  • Average True Range (ATR)
  • CHRO 0.12
  • FBGL 0.00
  • MACD
  • CHRO -0.01
  • FBGL 0.00
  • Stochastic Oscillator
  • CHRO 17.04
  • FBGL 0.00

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial and industrial building projects. As a green contractor focused on environmentally sound practices, It aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, lead lining, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts, sales of construction materials, and rendering of services.

Share on Social Networks: